These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19251424)

  • 21. Design and synthesis of bioactive adamantanaminoalcohols and adamantanamines.
    Zoidis G; Kolocouris N; Kelly JM; Prathalingam SR; Naesens L; De Clercq E
    Eur J Med Chem; 2010 Nov; 45(11):5022-30. PubMed ID: 20805012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of Adamantane Aminoethers with Antitubercular Potential.
    Foscolos AS; Papanastasiou I; Tsotinis A; Kolocouris N; Foscolos GB; Vocat A; Cole ST
    Med Chem; 2017; 13(7):670-681. PubMed ID: 28124614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: a human postmortem brain study.
    Kornhuber J; Bormann J; Hübers M; Rusche K; Riederer P
    Eur J Pharmacol; 1991 Apr; 206(4):297-300. PubMed ID: 1717296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stereoselective synthesis and pharmacological evaluation of [4.3.3]propellan-8-amines as analogs of adamantanamines.
    Torres-Gómez H; Lehmkuhl K; Frehland B; Daniliuc C; Schepmann D; Ehrhardt C; Wünsch B
    Bioorg Med Chem; 2015 Aug; 23(15):4277-4285. PubMed ID: 26145819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and pharmacological evaluation of fluorinated benzo[7]annulen-7-amines as GluN2B-selective NMDA receptor antagonists.
    Thum S; Schepmann D; Reinoso RF; Alvarez I; Ametamey SM; Wünsch B
    J Labelled Comp Radiopharm; 2019 Jun; 62(8):354-379. PubMed ID: 30850991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and Evaluation of Nifurtimox-Adamantane Adducts with Trypanocidal Activity.
    Foscolos AS; Papanastasiou I; Tsotinis A; Taylor MC; Kelly JM
    ChemMedChem; 2019 Jul; 14(13):1227-1231. PubMed ID: 31066972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Synthesis of derivatives of N-(1-adamantyl)-N'-urea with potential antiviral activity].
    Skwarski D; Maliszewska H
    Acta Pol Pharm; 1988; 45(5):391-4. PubMed ID: 3247849
    [No Abstract]   [Full Text] [Related]  

  • 28. Combined blockade of NMDA and AMPA receptors prevents acute kainate seizures and chronic kainate lethality in rats.
    Serdyuk SE; Gmiro VE; Veselkina OS
    Bull Exp Biol Med; 2014 May; 157(1):15-7. PubMed ID: 24906960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two blocking sites of amino-adamantane derivatives in open N-methyl-D-aspartate channels.
    Sobolevsky A; Koshelev S
    Biophys J; 1998 Mar; 74(3):1305-19. PubMed ID: 9512028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A comparative study of the central H-cholinergic-blocking and NMDA-blocking actions of MK-801, memantin, amantadine, pyrilen and IEM-1754 in experiments on intact rats].
    Gmiro VE; Serdiuk SE
    Eksp Klin Farmakol; 2000; 63(2):16-20. PubMed ID: 10834088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Synthesis and in vitro virucidal effect of recent 1-substituted adamantane derivatives].
    Sztaricskai F; Pelyvás I; Dinya Z; Szilágyi L; Györgydeák Z; Hadházy G; Váczi L; Bognár R
    Pharmazie; 1975 Sep; 30(9):571-81. PubMed ID: 1187737
    [No Abstract]   [Full Text] [Related]  

  • 32. Synthesis and antiviral activity evaluation of some new 6-substituted 3-(1-adamantyl)-1,2,4-triazolo[3,4-b][1,3,4]thiadiazoles.
    Kritsanida M; Mouroutsou A; Marakos P; Pouli N; Papakonstantinou-Garoufalias S; Pannecouque C; Witvrouw M; De Clercq E
    Farmaco; 2002 Mar; 57(3):253-7. PubMed ID: 11989804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiproliferative and antiviral activity of three libraries of adamantane derivatives.
    Basarić N; Sohora M; Cindro N; Mlinarić-Majerski K; De Clercq E; Balzarini J
    Arch Pharm (Weinheim); 2014 May; 347(5):334-40. PubMed ID: 24532384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of the adamantane structure in medicinal chemistry.
    Lamoureux G; Artavia G
    Curr Med Chem; 2010; 17(26):2967-78. PubMed ID: 20858176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel adamantane derivatives act as blockers of open ligand-gated channels and as anticonvulsants.
    Antonov SM; Johnson JW; Lukomskaya NY; Potapyeva NN; Gmiro VE; Magazanik LG
    Mol Pharmacol; 1995 Mar; 47(3):558-67. PubMed ID: 7535380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional in vitro characterization of CR 3394: a novel voltage dependent N-methyl-D-aspartate (NMDA) receptor antagonist.
    Losi G; Lanza M; Makovec F; Artusi R; Caselli G; Puia G
    Neuropharmacology; 2006 Mar; 50(3):277-85. PubMed ID: 16236334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Compounds with gastric antisecretory activity. 1. Phenoxyalkylamines.
    Cross PE; Dickinson RP; Kemp JE; Leeming PR; Pullman LG
    J Med Chem; 1977 Oct; 20(10):1317-23. PubMed ID: 903918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microwave assisted synthesis and anti-influenza virus activity of 1-adamantyl substituted N-(1-thia-4-azaspiro[4.5]decan-4-yl)carboxamide derivatives.
    Göktaş F; Vanderlinden E; Naesens L; Cesur N; Cesur Z
    Bioorg Med Chem; 2012 Dec; 20(24):7155-9. PubMed ID: 23117173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The pharmacology of aminoadamantane nitrates.
    Wang Y; Eu J; Washburn M; Gong T; Chen HS; James WL; Lipton SA; Stamler JS; Went GT; Porter S
    Curr Alzheimer Res; 2006 Jul; 3(3):201-4. PubMed ID: 16842096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, antifungal, antibacterial and antiviral effects of some adamantaneketoxime ethers.
    Papadaki-Valiraki A; Papakonstantinou-Garoufalias S; Marakos P; Chytyroglou-Lada A; Hosoya M; Balzarini J; de Clercq E
    Farmaco; 1993 Aug; 48(8):1091-102. PubMed ID: 8216671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.